Syndrome of arachnomelia in Simmental cattle by Buitkamp, Johannes, Luntz, Bernhard, Emmerling, Reiner, Reichenbach, Horst-Dieter, Weppert, Myriam, Schade, Benjamin, Meier, Norbert, Götz, Kay-Uwe

Get full text

Genetic diversity of European cattle breeds highlights the conservation value of traditional unselected breeds with high effective population size by Medugorac, Ivica, Medugorac, Ana, Russ, Ingolf, Veit-Kensch, Claudia E, Taberlet, Pierre, Luntz, Bernhard, Mix, Henry M, Forster, Martin

Get full text

Response-adapted lenalidomide maintenance in newly diagnosed myeloma: results from the phase III GMMG-MM5 trial by Goldschmidt, Hartmut, Mai, Elias K., Dürig, Jan, Scheid, Christof, Weisel, Katja C., Kunz, Christina, Bertsch, Uta, Hielscher, Thomas, Merz, Maximilian, Munder, Markus, Lindemann, Hans-Walter, Hügle-Dörr, Barbara, Tichy, Diana, Giesen, Nicola, Hose, Dirk, Seckinger, Anja, Huhn, Stefanie, Luntz, Steffen, Jauch, Anna, Elmaagacli, Ahmet, Rabold, Bernhard, Fuhrmann, Stephan, Brossart, Peter, Goerner, Martin, Bernhard, Helga, Hoffmann, Martin, Hillengass, Jens, Raab, Marc S., Blau, Igor W., Hänel, Mathias, Salwender, Hans J.

Get full text

Lenalidomide versus bortezomib maintenance after frontline autologous stem cell transplantation for multiple myeloma by Baertsch, Marc-Andrea, Mai, Elias K., Hielscher, Thomas, Bertsch, Uta, Salwender, Hans J., Munder, Markus, Fuhrmann, Stephan, Dührsen, Ulrich, Brossart, Peter, Neben, Kai, Schlenzka, Jana, Kunz, Christina, Raab, Marc S., Hillengaß, Jens, Jauch, Anna, Seckinger, Anja, Hose, Dirk, Luntz, Steffen, Sonneveld, Pieter, Lokhorst, Henk, Martin, Hans, Goerner, Martin, Hoffmann, Martin, Lindemann, Hans-Walter, Bernhard, Helga, Blau, Igor W., Scheid, Christof, Besemer, Britta, Weisel, Katja C., Hänel, Mathias, Dürig, Jan, Goldschmidt, Hartmut

Get full text

Bortezomib-based induction, high-dose melphalan and lenalidomide maintenance in myeloma up to 70 years of age by Mai, Elias K., Miah, Kaya, Bertsch, Uta, Dürig, Jan, Scheid, Christof, Weisel, Katja C., Kunz, Christina, Munder, Markus, Lindemann, Hans-Walter, Merz, Maximilian, Hose, Dirk, Jauch, Anna, Seckinger, Anja, Luntz, Steffen, Sauer, Sandra, Fuhrmann, Stephan, Brossart, Peter, Elmaagacli, Ahmet, Goerner, Martin, Bernhard, Helga, Hoffmann, Martin, Raab, Marc S., Blau, Igor W., Hänel, Mathias, Benner, Axel, Salwender, Hans J., Goldschmidt, Hartmut

Get full text

Publisher Correction: Bortezomib-based induction, high-dose melphalan and lenalidomide maintenance in myeloma up to 70 years of age by Mai, Elias K., Miah, Kaya, Bertsch, Uta, Dürig, Jan, Scheid, Christof, Weisel, Katja C., Kunz, Christina, Munder, Markus, Lindemann, Hans-Walter, Merz, Maximilian, Hose, Dirk, Jauch, Anna, Seckinger, Anja, Luntz, Steffen, Sauer, Sandra, Fuhrmann, Stephan, Brossart, Peter, Elmaagacli, Ahmet, Goerner, Martin, Bernhard, Helga, Hoffmann, Martin, Raab, Marc S., Blau, Igor W., Hänel, Mathias, Benner, Axel, Salwender, Hans J., Goldschmidt, Hartmut

Get full text

Isatuximab, Lenalidomide, Bortezomib and Dexamethasone Induction Therapy for Transplant-Eligible Patients with Newly Diagnosed Multiple Myeloma: Final Progression-Free Survival Ana... by Goldschmidt, Hartmut, Bertsch, Uta, Pozek, Ema, Benner, Axel, Fenk, Roland, Besemer, Britta, Hanoun, Christine, Schroers, Roland, von Metzler, Ivana, Hänel, Mathias, Mann, Christoph, Leypoldt, Lisa, Heilmeier, Bernhard, Huhn, Stefanie, Vogel, Sabine, Hundemer, Michael, Scheid, Christof, Blau, Igor Wolfgang, Luntz, Steffen, Holderried, Tobias A.W., Trautmann-Grill, Karolin, Gezer, Deniz, Klaiber-Hakimi, Maika, Mueller, Martin, Shumilov, Evgenii, Knauf, Wolfgang, Michel, Christian Sebastian, Geer, Thomas, Riesenberg, Hendrik, Lutz, Christoph, Raab, Marc-Steffen, Hoffmann, Martin, Weisel, Katja C., Salwender, Hans, Mai, Elias K.

Get full text

Impact of Minimal Residual Disease on Progression-Free Survival in Patients with Newly Diagnosed Multiple Myeloma Treated with Isatuximab, Lenalidomide, Bortezomib and Dexamethason... by Mai, Elias K., Salwender, Hans, Hundemer, Michael, Bertsch, Uta, Pozek, Ema, Benner, Axel, Fenk, Roland, Besemer, Britta, Hanoun, Christine, Schroers, Roland, von Metzler, Ivana, Hänel, Mathias, Mann, Christoph, Leypoldt, Lisa, Heilmeier, Bernhard, Huhn, Stefanie, Vogel, Sabine, Scheid, Christof, Wolfgang Blau, Igor, Luntz, Steffen, Weinhold, Niels, Holderried, Tobias A.W., Trautmann-Grill, Karolin, Gezer, Deniz, Klaiber-Hakimi, Maika, Mueller, Martin, Shumilov, Evgenii, Knauf, Wolfgang, Michel, Christian Sebastian, Geer, Thomas, Riesenberg, Hendrik, Lutz, Christoph, Raab, Marc S., Hoffmann, Martin, Weisel, Katja C., Goldschmidt, Hartmut

Get full text

Addition of Isatuximab to Lenalidomide, Bortezomib and Dexamethasone As Induction Therapy for Newly-Diagnosed, Transplant-Eligible Multiple Myeloma Patients: The Phase III GMMG-HD7... by Goldschmidt, Hartmut, Mai, Elias K, Nievergall, Eva, Fenk, Roland, Bertsch, Uta, Tichy, Diana, Besemer, Britta, Dürig, Jan, Schroers, Roland, Metzler, Ivana v., Haenel, Mathias, Mann, Christoph, Asemissen, Anne-Marie, Heilmeier, Bernhard, Huhn, Stefanie, Kriegsmann, Katharina, Weinhold, Niels, Luntz, Steffen P., Holderried, Tobias A.W., Trautmann-Grill, Karolin, Gezer, Deniz, Klaiber-Hakimi, Maika, Mueller, Martin, Khandanpour, Cyrus, Knauf, Wolfgang, Munder, Markus, Geer, Thomas, Riesenberg, Hendrik, Thomalla, Joerg, Hoffmann, Martin, Raab, Marc-Steffen, Salwender, Hans, Weisel, Katja

Get full text

Prognostic Impact of Serum Free Light Chain Ratio Normalization in Patients with Multiple Myeloma Treated within the GMMG-MM5 Trial by Klein, Eva-Maria, Tichy, Diana, Salwender, Hans, Mai, Elias, Duerig, Jan, Weisel, Katja, Benner, Axel, Bertsch, Uta, Akhavanpoor, Mabast, Besemer, Britta, Munder, Markus, Lindemann, Hans-Walter, Hose, Dirk, Seckinger, Anja, Luntz, Steffen, Jauch, Anna, Elmaagacli, Ahmet, Fuhrmann, Stephan, Brossart, Peter, Goerner, Martin, Bernhard, Helga, Raab, Marc, Blau, Igor, Haenel, Mathias, Scheid, Christof, Goldschmidt, Hartmut

Get full text

Normalization of serum free light chains during therapy in the MM5 trial predicts prolonged progression free survival and overall survival by Haas, Eva-Maria, Salwender, Hans J., Mai, Elias K., Dürig, Jan, Weisel, Katja, Tichy, Diana, Benner, Axel, Kunz, Christina, Hielscher, Thomas, Bertsch, Uta, Besemer, Britta, Merz, Maximilian, Munder, Markus, Lindemann, Hans-Walter, Hügle-Dörr, Barbara, Giessen, Nicola, Hose, Dirk, Seckinger, Anja, Huhn, Stefanie, Luntz, Steffen, Jauch, Anna, Elmaagacli, Ahmet, Rabold, Bernhard, Fuhrmann, Stephan, Brossart, Peter, Goerner, Martin, Bernhard, Helga, Hoffmann, Martin, Hillengass, Jens, Raab, Marc S., Blau, Igor Wolfgang, Haenel, Mathias, Scheid, Christof, Goldschmidt, Hartmut

Get full text

PF597 HIGH DOSE MELPHALAN (200MG/M2) AND AUTOLOGOUS TRANSPLANTATION IN NEWLY‐DIAGNOSED MULTIPLE MYELOMA UP TO THE AGE OF 70 YEARS: A SUBGROUP ANALYSIS FROM THE PHASE III GMMG‐MM5 T... by Mai, E.K., Miah, K., Merz, M., Dürig, J., Scheid, C., Weisel, K.C., Kunz, C., Bertsch, U., Munder, M., Lindemann, H.‐W., Hose, D., Jauch, A., Seckinger, A., Luntz, S., Sauer, S., Fuhrmann, S., Brossart, P., Elmaagacli, A., Goerner, M., Bernhard, H., Hoffmann, M., Raab, M.S., Blau, I.W., Hänel, M., Benner, A., Salwender, H.J., Goldschmidt, H.

Request full text